EX-10.1 2 d591613dex101.htm EX-10.1 June 3, 2018 William Lis Portola Pharmaceuticals, Inc. South San Francisco, CA 94080 Dear Bill:California • May 5th, 2020
Jurisdiction FiledMay 5th, 2020This letter sets forth the substance of the transition, separation and consulting agreement (the “Agreement”) between you and Portola Pharmaceuticals, Inc. (the “Company”).
June 3, 2018 William Lis Portola Pharmaceuticals, Inc. South San Francisco, CA 94080 Dear Bill:Portola Pharmaceuticals Inc • June 4th, 2018 • Pharmaceutical preparations • California
Company FiledJune 4th, 2018 Industry JurisdictionThis letter sets forth the substance of the transition, separation and consulting agreement (the “Agreement”) between you and Portola Pharmaceuticals, Inc. (the “Company”).